Arkolith/Insider Trading/SQZ/Form 4

Schulman Amy W

Director, 10% OwnerSQZ Biotechnologies Co (SQZ) · full profile →Form 4 · filed Dec 23, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 22, 2021Option exercise(M)10K$2.02$20K201K
Dec 22, 2021Option exercise(M)7K$4.59$30K215K
Dec 22, 2021Option exercise(M)7K$4.59$34K208K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 22, 2021Option exercise(M)10K—$0439
Dec 22, 2021Option exercise(M)7K—$03K
Dec 22, 2021Option exercise(M)7K—$04K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-071110) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML